SARS-CoV-2 detection in saliva samples (SDS)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032803

Enrollment

490

Registered

2023-10-05

Start date

2023-10-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensitivity/specificity of the Lolli method for the detection of respiratory viruses

Interventions

Group 1: Volunteers with PCR-confirmed viral infection in the last 21 days, volunteers with clinical or epidemiological suspicion of respiratory virus infection, PCR-confirmed negative subjects. Indiv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Consent from the subject or both legal guardians - Consent from the children, provided they are capable of giving consent themselves (from around 14 years of age) - Declaration of intent for children under 14 years of age - Good physical condition (Karnofsky index =80%) - PCR confirmed infection with one of the mentioned respiratory viruses in the last 21 days and/or clinical or epidemiological suspicion of infection (symptoms of infection with a respiratory virus: cough, runny nose, fever, chills and/or association with a known wave of infections with a respiratory virus) - PCR confirmed negative subjects

Exclusion criteria

Exclusion criteria: - No ability to consent - Refusal to participate - Employment at the Institute of Virology, University Hospital Cologne

Design outcomes

Primary

Measure	Time frame
Virus detection in saliva samples	—

Secondary

Measure	Time frame
Differences in virus concentration in nasal/throat swabs compared to saliva samples, assessment of the different saliva collection methods	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026